NCT01530178View on ClinicalTrials.gov

Sitagliptin Dose Determination Study

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Sitagliptin

In each intervention arm the participant receives a different dose of sitagliptin.

DRUG

Placebo Oral Tablet

Trial Locations (1)

10461

Albert Einstein College of Medicine CRC, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER

NCT01530178 - Sitagliptin Dose Determination Study | Biotech Hunter | Biotech Hunter